Sign In
to Vote &
Create Storyboards.
 
Intarcia Diabetes Implant Shows Promising Results During Phase 3 Trials U.S.-based pharmaceutical company Intarcia Therapeutics reported that its new diabetes pump known as ITCA 650 was able to reduce weight and lower blood glucose levels better than Merck & Co's best-selling product Januvia.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard